Bruker Corporation has announced the launch of their new timsUltra AIP System, a groundbreaking advancement designed to enhance the sensitivity and capabilities of single-cell proteomics, FNA biopsy immunopeptidomics, and metaproteomics research. This innovative system allows scientists to explore life and materials at molecular, cellular, and microscopic levels with unprecedented precision. The timsUltra AIP System represents a significant leap in post-genomic life science research, supporting applications in preclinical imaging, clinical phenomics, proteomics, and multiomics. By providing high performance scientific instruments and analytical solutions, Bruker continues to facilitate innovation and improved productivity in fields such as molecular and cell biology, microscopy, and next-gen semiconductor metrology, ultimately contributing to advancements in human health and technology.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。